QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
16.32
-1.18 (-6.72%)
At close: Aug 6, 2026, 4:00 PM EDT
13.00
-3.32 (-20.34%)
After-hours: Aug 6, 2026, 5:44 PM EDT
QuidelOrtho Revenue
QuidelOrtho had revenue of $630.90M in the quarter ending June 28, 2026, with 2.77% growth. This brings the company's revenue in the last twelve months to $2.67B, down -2.46% year-over-year. In the year 2025, QuidelOrtho had annual revenue of $2.73B, down -1.89%.
Revenue (ttm)
$2.67B
Revenue Growth
-2.46%
P/S Ratio
0.42
Revenue / Employee
$408,800
Employees
6,500
Market Cap
1.11B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.73B | -52.70M | -1.89% |
| Dec 31, 2024 | 2.78B | -214.90M | -7.17% |
| Dec 31, 2023 | 3.00B | -268.20M | -8.21% |
| Jan 1, 2023 | 3.27B | 1.57B | 92.28% |
| Jan 2, 2022 | 1.70B | 36.90M | 2.22% |
| Jan 3, 2021 | 1.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Enovis | 2.30B |
| Integra LifeSciences Holdings | 1.65B |
| CONMED | 1.37B |
| Lumexa Imaging Holdings | 1.03B |
| Tandem Diabetes Care | 1.03B |
| Alphatec Holdings | 815.05M |
| Bioventus | 581.85M |
| Artivion | 458.69M |
QDEL News
- 52 minutes ago - QuidelOrtho Earnings release: Q2 2026 - Filings
- 1 hour ago - QuidelOrtho reports Q2 adjusted EPS 13c, consensus (5c) - TheFly
- 1 hour ago - QuidelOrtho cuts FY26 adjusted EPS view to 65c-90c from $1.80-$2.00 - TheFly
- 1 hour ago - QuidelOrtho Reports Second Quarter 2026 Financial Results - PRNewsWire
- 13 days ago - QuidelOrtho to Report Second Quarter 2026 Financial Results - PRNewsWire
- 14 days ago - Beyond Fentanyl: How the Drug Crisis Is Changing - PRNewsWire
- 21 days ago - QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - QuidelOrtho price target raised to $18 from $13 at Citi - TheFly